PMID- 20693204
OWN - NLM
STAT- MEDLINE
DCOM- 20101124
LR  - 20220310
IS  - 1477-0962 (Electronic)
IS  - 0961-2033 (Linking)
VI  - 19
IP  - 9
DP  - 2010 Aug
TI  - Drug-induced subacute cutaneous lupus erythematosus.
PG  - 1107-11
LID - 10.1177/0961203310370349 [doi]
AB  - Subacute cutaneous lupus erythematosus (SCLE) is a subset of cutaneous lupus 
      erythematosus with unique immunologic and clinical features. The first 
      description dates back to 1985 when a series of five patients were found to have 
      hydrochlorothiazide-induced SCLE. Since that time, at least 40 other drugs have 
      been implicated in the induction of SCLE.
FAU - Callen, J P
AU  - Callen JP
AD  - Division of Dermatology, Department of Medicine, University of Louisville School 
      of Medicine, Louisville, KY, USA. jefca@aol.com
LA  - eng
PT  - Journal Article
PT  - Review
PL  - England
TA  - Lupus
JT  - Lupus
JID - 9204265
RN  - 0J48LPH2TH (Hydrochlorothiazide)
SB  - IM
MH  - *Drug-Related Side Effects and Adverse Reactions
MH  - Humans
MH  - Hydrochlorothiazide/adverse effects
MH  - Lupus Erythematosus, Cutaneous/*chemically induced/immunology/pathology
MH  - Photosensitivity Disorders/chemically induced
MH  - Skin/*pathology
EDAT- 2010/08/10 06:00
MHDA- 2010/12/14 06:00
CRDT- 2010/08/10 06:00
PHST- 2010/08/10 06:00 [entrez]
PHST- 2010/08/10 06:00 [pubmed]
PHST- 2010/12/14 06:00 [medline]
AID - 19/9/1107 [pii]
AID - 10.1177/0961203310370349 [doi]
PST - ppublish
SO  - Lupus. 2010 Aug;19(9):1107-11. doi: 10.1177/0961203310370349.